4//SEC Filing
Beddingfield III Frederick 4
Accession 0001562180-19-004216
CIK 0001656328other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:38 PM ET
Size
30.8 KB
Accession
0001562180-19-004216
Insider Transaction Report
Form 4
Beddingfield III Frederick
DirectorPresident & CEO
Transactions
- Disposition to Issuer
Stock Options (Right to buy)
2019-08-06−42,590→ 0 totalExercise: $15.00Exp: 2027-07-26→ Common Stock (42,590 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2019-08-06−40,968→ 0 totalExercise: $2.32From: 2019-01-01Exp: 2029-01-01→ Common Stock (40,968 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2019-08-06−93,750→ 0 totalExercise: $2.32Exp: 2029-01-01→ Common Stock (93,750 underlying) - Award
Common Stock
2019-08-06+150,000→ 967,599 total - Disposition to Issuer
Stock Options (Right to buy)
2019-08-06−190,910→ 0 totalExercise: $15.08Exp: 2028-06-01→ Common Stock (190,910 underlying) - Award
Stock Options (Right to buy)
2019-08-06+40,968→ 40,968 totalExercise: $0.71From: 2019-01-01Exp: 2029-01-01→ Common Stock (40,968 underlying) - Award
Stock Options (Right to buy)
2019-08-06+190,910→ 190,910 totalExercise: $0.71Exp: 2028-06-01→ Common Stock (190,910 underlying) - Award
Stock Options (Right to buy)
2019-08-06+93,750→ 93,750 totalExercise: $0.71Exp: 2029-01-01→ Common Stock (93,750 underlying) - Award
Stock Options (Right to buy)
2019-08-06+93,750→ 93,750 totalExercise: $0.71Exp: 2029-01-01→ Common Stock (93,750 underlying) - Award
Stock Options (Right to buy)
2019-08-06+42,590→ 42,590 totalExercise: $0.71Exp: 2027-07-26→ Common Stock (42,590 underlying) - Disposition to Issuer
Stock Options (Right to buy)
2019-08-06−93,750→ 0 totalExercise: $2.32Exp: 2029-01-01→ Common Stock (93,750 underlying)
Holdings
- 112,614(indirect: See Footnote)
Common Stock
Footnotes (8)
- [F1]Award of restricted stock units ("RSUs") granted under the Issuer's 2017 Incentive Award Plan. Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting. The award vests as to fifty percent (50%) of the total number of RSUs on February 6, 2020, twenty-five percent (25%) of the total number of RSUs on August 6, 2020, and the remaining twenty-five percent (25%) of the total number of RSUs on February 6, 2021, in each case, subject to the Reporting Person's continued employment or service relationship with the Issuer through the applicable vesting date.
- [F2]Includes a total of 5,916 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]The shares are directly held by the Beddingfield Family Trust.
- [F4]The transaction reported herein reflect a one-time stock option repricing (the "Option Repricing") that became effective on August 6, 2019 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of each relevant option has been amended to reduce such exercise price to $0.71. There have been no other changes to the terms of the relevant options.
- [F5]Twenty-Five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from June 1, 2018, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- [F6]Twenty-Five percent (25%) of the share subject to the option vest and become exercisable on the first anniversary measured from July 26, 2017, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- [F7]Twenty percent (20%) of the shares subject to the option vest and become exercisable upon satisfaction of one performance-based milestone, forty percent (40%) of the shares vest and become exercisable upon satisfaction of a second performance-based milestone, and the remaining forty percent (40%) of the shares vest and become exercisable upon satisfaction of a third performance-based milestone, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- [F8]Twenty-five percent (25%) of the shares subject to the option vest and become exercisable on July 1,2019, twenty-five percent (25%) of the shares vest and become exercisable on January 1, 2020, and the remaining shares vest and become exercisable in 12 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Entity typeother
Related Parties
1- filerCIK 0001573074
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:38 PM ET
- Size
- 30.8 KB